CentralReach, a company at the forefront of autism care technology, has recently engaged investment bank William Blair to explore a potential sale. Founded in 2012, the company has grown into a leading provider of electronic health records (EHR) software specifically tailored for autism and related intellectual and developmental disorders. This specialized focus has positioned CentralReach as a crucial player in the autism care ecosystem, with its technology now used by over 175,000 healthcare professionals worldwide.
The company’s software goes beyond traditional EHR systems, offering AI-powered tools designed to streamline and automate various aspects of autism care. These innovations have significantly improved the efficiency and effectiveness of autism treatment, allowing healthcare providers to better manage patient care, track progress, and implement evidence-based interventions.
CentralReach’s growth strategy has been aggressive, with 14 acquisitions in its 13-year history. The most recent addition to its portfolio was Behavior Science Technology in September, further enhancing its capabilities in autism care technology. This expansion has not only broadened CentralReach’s service offerings but also solidified its position as a comprehensive solution provider in the autism care space.
While the company has been discreet about its financials, industry sources suggest CentralReach is generating approximately $75 million in earnings before interest, taxes, depreciation, and amortization (EBITDA). This robust financial performance, coupled with its niche focus on autism care, has led to considerations of a potential sale valuing the company at over $1 billion.
The exploration of a sale by CentralReach comes at a time when the demand for specialized healthcare technology, particularly in areas like autism care, is on the rise. As awareness and diagnosis of autism spectrum disorders continue to increase, the need for efficient, technology-driven care solutions becomes more critical. CentralReach’s potential sale could therefore have significant implications for the future of autism care technology and the broader healthcare technology sector.
Citations:
- https://bhbusiness.com/2025/03/10/centralreach-reportedly-considering-exit-eyes-1b-valuation/
- https://africa.businessinsider.com/news/autism-care-software-company-centralreach-tapped-william-blair-to-explore-a-sale/80ypl2v
- https://www.businessinsider.com/healthcare-company-centralreach-william-blair-to-pursue-sale-2025-3
- https://centralreach.com/blog/centralreach-expands-its-prek-12-education-software-offering-through-the-acquisition-of-lifted-a-purpose-built-software-application-for-special-education-programs/
- https://www.linkedin.com/posts/rebecca-torrence_autism-care-software-company-centralreach-activity-7302487357562257408-6LRb
- https://www.roi-nj.com/2022/06/09/education/centralreach-increasing-reach-in-autism-and-idd-care-software-acquires-lifted/
- https://growthcapadvisory.com/the-top-women-leaders-in-growth-investing-of-2023/
- https://bhbusiness.com/category/finance/ma/
